Phaseline

Companies › Brainfarma Industria Química e Farmacêutica S/A

Brainfarma Industria Química e Farmacêutica S/A: clinical trials, targets and expected readouts

2 active drug programs in 10 registered trials: 5 Phase 4, 3 Phase 3, 2 Phase 2; Neurology, Cardiovascular, Metabolic and endocrine, Oncology; next expected readout Jun 2027.

Open in Phaseline: competitors, likelihood bands and readouts Company report

Programs

DrugTargetHighest phaseConditionsNext expected readout
Pregabalin
Voltage-gated calcium channel modulator
Ion channels, CACNB4, CACNB2, CACNB1, CACNB3Phase 3Diabetic Neuropathy; Shoulder Arthropathy; Pregabalin; Diabetic Pruritus …Jun 2027
Dipyrone
Cyclooxygenase inhibitor
PTGS2, PTGS1Phase 3Common Cold/Flu; Hematologic TestJun 2027

Trials

Registry idDrugPhaseConditionsAreaExpected readout
NCT05488847PregabalinPhase 4Shoulder ArthropathyOtherDec 2024
NCT05640453PregabalinPhase 4PregabalinCardiovascularMay 2026
NCT06790537PregabalinPhase 4Diabetic PruritusMetabolic and endocrineJun 2026
NCT06150898PregabalinPhase 2Early-stage Breast CancerOncologyApr 2027
NCT07712913PregabalinPhase 3Diabetic NeuropathyNeurologyJun 2027
NCT07626437DipyronePhase 3Common Cold/FluInfectious diseaseJun 2027
NCT07626437DipyronePhase 3Common Cold/FluInfectious diseaseJun 2027
NCT07918040DipyronePhase 4Hematologic TestHematologyJul 2027
NCT06614322PregabalinPhase 2Painful Peripheral NeuropathyNeurologyJun 2028
NCT07076069PregabalinPhase 4Rotator Cuff RepairsOtherJun 2028

Targets

Ion channels (1) CACNB4 (1) CACNB2 (1) CACNB1 (1) CACNB3 (1) PTGS2 (1) PTGS1 (1)

Companies with the same targets

Viatris Xenon Pharmaceuticals Praxis Precision Medicines Laboratorios Silanes S.A. de C.V. HB BioTech Encoded Therapeutics Biohaven Therapeutics TLC Biopharmaceuticals Shenzhen Ausa Pharmed Grace Therapeutics

Companies built like this

Laboratorios Silanes S.A. de C.V. Tiohundra Laboratorio Elea Phoenix Soleno Therapeutics Shenzhen Ausa Pharmed

Pipelines of the same shape: areas, drug types, target families, stage and cash runway.

Programs group the company's trials by drug; the target and mechanism come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood, shown as a band with its track record, is in the app.